Epigral Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited's promoters — Jayantibhai Meghjibhai Patel, Ashishbhai Natawarlal Soparkar, Natwarlal Meghjibhai Patel, Rameshbhai Meghjibhai Patel, Anandbhai Ishwarbhai Patel, Maulikbhai Jayantibhai Patel, and Kaushalbhai Ashishbhai Soparkar — have each submitted a Regulation 31(4) declaration to NSE and BSE. Under this SEBI (Substantial Acquisition of Shares and Takeovers) regulation, promoters are required to annually confirm whether they have created any encumbrance (such as a pledge or lien) on their shares in the company. All seven promoters, acting on behalf of themselves and the broader promoter group, have confirmed that no encumbrance was created, directly or indirectly, on their shares in Epigral during the financial year ended 31st March 2025. The filings are dated 2nd April 2025 and are routine annual compliance submissions.
This is a routine regulatory disclosure and not an action that affects shareholder value. The fact that promoters have not pledged or otherwise encumbered their shares is a neutral-to-slightly-positive signal, indicating no hidden leverage or forced-sale risk from the promoter group as of FY-end.